Gómez-Iturriaga Piña, Alfonso <br/><br/>
Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer.  [electronic resource] 

 -  Urology  Jun 2010 
 - 1412-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2009.04.101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Biopsy, Needle<br/>Brachytherapy--adverse effects<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Erectile Dysfunction--etiology<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Iodine Radioisotopes--therapeutic use<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Probability<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--mortality<br/>Radiation Injuries--prevention & control<br/>Radiotherapy Dosage<br/>Radiotherapy Planning, Computer-Assisted--methods<br/>Relative Biological Effectiveness<br/>Retrospective Studies<br/>Risk Assessment<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome<br/>Urinary Incontinence--etiology